Collaborators

He trained and received his doctorate in Hematology at the Hospital Clínico de Barcelona. </br></br> He was a visiting researcher at the Center for the Study of Systemic Amyloidoses (Pavia), at the National Cancer Institute (Bethesda, USA) and at the Memorial Sloan Kettering Cancer Center (New York) for 18 months, where he worked with CAR T-cells for myeloma. </br></br> He is currently a consultant at the Department of Hematology at Hospital Clínic, group leader at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and associate professor at the University of Barcelona.
Dr. Carlos Fernández de Larrea

Director

He completed his training in Hematology at the Hospital Clínic of Barcelona and since then his clinical, research and teaching activity has focused on the field of monoclonal gammopathies. He wrote his Doctoral Thesis on multiple myeloma (2009) and spent a year at the Amyloid Treatment and Research Program in Boston (2009-2010). He is currently a senior specialist in the Hematology Service of the Hospital Clínic of Barcelona.
Dr. Mª Teresa Cibeira López

Senior Specialist of the Hematology Service of the Hospital Clínico de Barcelona

He completed his training and doctorate in Hematology at the Hospital Clínic. He completed a postdoctoral stay at the University Hospital of Würzburg Germany and later at IDIBAPS, working on CAR-T therapy for myeloma. He is currently a specialist in the Department of Hematology at the Hospital Clínic of Barcelona and an accredited researcher in IDIBAPS.
Dr. Luis Gerardo Rodríguez-Lobato

Senior Specialist Doctor of the Hematology Service of the Hospital Clinic

She has a degree in Psychology from the University of Barcelona. He has expanded his training with different courses focused on clinical quality and safety.</br></br> Desde el año 2017, ha colaborado con los grupos de investigación del Dr. Joan Bladé (Mieloma Múltiple) y con el Dr. Armando López- Guillermo (Neoplásias Limfoides) </br></br> Actualmente, ejerce como secretaria de Dirección del Instituto de Enfermedades Hematológicas y Oncológicas del Hospital Clínic de Barcelona, y secretaria personal del Dr. Alvaro Urbano, Director del Instituto.
Mrs. Vanessa Arellano

Project Manager

He completed his training as a specialist in Hematology and completed his doctorate in the immune response in multiple myeloma at the Hospital Clínic. Since then, she has worked in the new therapies unit of the same hospital as a clinical researcher in the use of new drugs including CART therapy or bispecific antibodies, mainly for patients with multiple myeloma or other gammopathies.
Dr. Natalia Tovar

Doctor specializing in Hematology at the Hospital Clínic of Barcelona

He graduated in Medicine from the University of Barcelona in 1996. He completed his training as a specialist in Hematology and Hemotherapy at the Hospital Clínico de Barcelona and received his doctorate from the University of Barcelona for his work in molecular genetics in quiescent myeloma. She has been part of the Hematology Service of the Hospital Clínic since 2006 and is currently the head of the Myeloma and Amyloidosis Unit. His professional career has focused on clinical research into monoclonal gammopathies, participating in the design and analysis of numerous multiple myeloma clinical trials.
Dr. Laura Rosiñol

Doctor specializing in Hematology at the Hospital Clínic of Barcelona. Head of the Myeloma and Amyloidosis Unit.

He studied Biochemistry at Imperial College London before completing his PhD in Cell Biology/Biochemistry at the University of Bristol, UK. Dr. Battram subsequently moved to Scotland to work in the laboratory of Prof. Doreen Cantrell at the University of Dundee, where he researched the biology of T lymphocytes. Since 2020, Dr. Battram has been working on improving cells CAR-T for multiple myeloma as a postdoctoral researcher at IDIBAPS in Barcelona
Dr. Anthony Battram

Post-Doctoral Researcher (R2A)